Iradimed Corp. (IRMD) Tops Q2 EPS by 5c

Go back to Iradimed Corp. (IRMD) Tops Q2 EPS by 5c

Roth Capital Upgrades IRadimed Corp (IRMD) to Buy

July 31, 2017 8:33 AM EDT

Roth Capital upgraded IRadimed Corp (NASDAQ: IRMD) from Neutral to Buy.

For an analyst ratings summary and ratings history on IRadimed Corp click here. For more ratings news on IRadimed Corp click here.

Shares of IRadimed Corp closed at $9.80 Friday.

... More